Medical Device and Method for Glycemic Control
First Claim
1. A method for determining a dose of insulin to be administered for glycemic control, wherein the dose is stepwise adapted, the method comprising the steps of:
- determining a blood glucose value,receiving glycemic event information in respect to a predetermined glycemic event, wherein the predetermined glycemic event occurred within a predetermined time interval,receiving a previously adapted dose value stored in a storage unit, andsetting an alert based on at least the blood glucose value, the glycemic event information and the previously adapted dose, wherein the alert indicates that the blood glucose value and the predetermined glycemic event are not in a specified relation to the previously adapted dose value.
1 Assignment
0 Petitions
Accused Products
Abstract
A medical device and method for determining a dose of insulin to be administered for glycemic control is provided, wherein the dose is stepwise adapted, comprising determining a blood glucose value, receiving glycemic event information in respect to a predetermined glycemic event, wherein the predetermined glycemic event occurred within a predetermined time interval, receiving a previously adapted dose value stored in a storage unit, and setting an alert based on at least the blood glucose value, the glycemic event information and the previously adapted dose, wherein the alert indicates that the blood glucose value and the predetermined glycemic event are not in a specified relation to the previously adapted dose value.
37 Citations
16 Claims
-
1. A method for determining a dose of insulin to be administered for glycemic control, wherein the dose is stepwise adapted, the method comprising the steps of:
-
determining a blood glucose value, receiving glycemic event information in respect to a predetermined glycemic event, wherein the predetermined glycemic event occurred within a predetermined time interval, receiving a previously adapted dose value stored in a storage unit, and setting an alert based on at least the blood glucose value, the glycemic event information and the previously adapted dose, wherein the alert indicates that the blood glucose value and the predetermined glycemic event are not in a specified relation to the previously adapted dose value. - View Dependent Claims (2, 3, 4, 5, 6, 7)
-
-
8. A device for determining a dose of insulin to be administered for glycemic control, the device comprising:
-
a blood glucose determining unit adapted to determine a blood glucose value, a storage unit adapted to store a previously adapted dose value, a receiving unit arranged to receive a glycemic event information in respect to a predetermined glycemic event within a predetermined time interval and for receiving the previously adapted dose value stored in a storage unit, adapting means arranged to stepwise adapting the dose according to the output of the receiving unit and the determining unit, and an alert unit adapted to set an alert based on at least the blood glucose value, the glycemic event information and the previously adapted dose, wherein the alert unit is adapted to create the alert indicating that the blood glucose value and the predetermined glycemic event are not in a specified relation to the previously adapted dose value. - View Dependent Claims (9, 10, 11, 12, 13, 14)
-
-
15. A computer program for determining a dose of insulin to be administered for glycemic control, wherein the dose is stepwise adapted, the computer program comprising:
-
code for receiving a blood glucose value; code for receiving glycemic event information in respect to a predetermined glycemic event, wherein the predetermined glycemic event occurred within a predetermined time interval; code for receiving a previously adapted dose value stored in a storage unit; and code for setting an alert based on at least the blood glucose value, the glycemic event information and the previously adapted dose, wherein the alert indicates that the blood glucose value and the predetermined glycemic event are not in a specified relation to the previously adapted dose value. - View Dependent Claims (16)
-
Specification